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INTRODUCTION 
Clostridium botulinum produces a botulinum neurotoxin (BoNT; 150 kDa) that is 
the causative agent of human and animal botulism. After the absorption from intestine, 
BoNT enters nerve cells via receptor-mediated endocytosis and cleaves specific sites on 
target proteins through its zinc protease activity. This results in the inhibition of 
acetylcholine release from peripheral cholinergic nerves, reading to flaccid muscle 
paralysis (Montecucco and Schiavo 1993). BoNT is serologically classified into seven 
serotypes A through G. Serotype A, B, E and F are mainly responsible for human 
botulism, whereas serotypes C and D causes in animal and avian botulism. Food borne 
botulism occurs every 2 or 3 years in Japan, although the case of death has never been 
reported since 1986. On the other hand, sporadic and massive outbreaks of cattle 
botulism have occurred worldwide in recent years. In Japan, one to five cases of cattle 
botulism have been reported every year, causing large economic losses in dairy and beef 
cattle farming (Cobb et al. 2002; Martin 2003; Steinman et al. 2007). 
In culture supernatant and naturally contaminated foods, BoNT molecule is 
associated with auxiliary proteins including nontoxic nonhemagglutinin (NTNHA; 130 
kDa) and hemagglutinin (HA) subcomponents having molecular mass of 70, 33 and 17 
kDa (HA-70, HA-33 and HA-17), yielding botulinum toxin complex (TC). C. botulinum 
produces different forms of TC depending on serotypes. Serotype A-D strains produce 
the M-TC (a complex of single BoNT and single NTNHA) and L-TC (a complex of 
M-TC and some HA components). Serotype A strain also produce LL-TC that is thought 
to be a dimer of L-TC (Oguma et al. 1999). On the other hand, serotype E and F strains 
produce only M-TC. Although the three dimensional (3D) structure of L-TC has long 
been obscure, a recent study by Hasegawa et al. (2007) clarified that L-TC is 14-mer 
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protein consists of a single BoNT, a single NTNHA, three HA-70, three HA-17 and six 
HA-33 molecules, and that L-TC has an ellipsoidal-shaped structure with three 
extended ‘‘arms’’ of the HA-33/HA-17 (2:1) trimer.  
When ingested orally, pure BoNT molecule is easily degraded and losses its 
toxicity, whereas an association of BoNT with NTNHA molecule amazingly enhances 
the stability against gastric acid and proteolytic conditions, enabling BoNT molecules to 
reach the intestine. Thus NTNHA protects BoNT molecule from digestion with harsh 
conditions of gastrointestinal tract. On the other hand, HA-33/HA-17 trimer is thought 
to contribute to the effective transport of the toxin across the intestinal epithelia. It has 
been shown that HA-33 binds to cells such as erythrocyte and intestinal cells via sugar 
chains on the cell surface. Fujinaga et al. (2000) showed that type A L-TC (L-TC/A) 
recognizes galactose residues of these cells. It was also reported that HA-33 of L-TC/A 
binds to erythrocytes via galactose moiety (Inoue et al. 2001). A recent report showed 
that HA-33 of type B L-TC (HA-33/B) bound to porcine gastric mucin, whose 
carbohydrate moiety is devoid of sialic acid, but not to bovine submaxillary mucin, 
which is rich in sialic acid (Sugawara et al. 2014). Thus HA-33/A and B predominantly 
recognizes galactose. In contrast, it has been shown that HA-33 of serotype C and D 
L-TC (HA-33/C and D) preferentially binds to sialic acid moiety but not galactose 
moiety on the cell surface. Niwa et al. (2010) showed that both binding and permeation 
of HA-33/HA-17 trimer of serotype D were potently inhibited by N-acetyl neuraminic 
acid in the cell culture medium or by treatment of the cells with neuraminidase. 
However, neither galactose, lactose nor N-acetyl galactosamine inhibited binding or 
permeation of the complex. Similar results were observed in HA-33/HA-17 trimer of 
serotype C (Inui et al. 2010). 
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It has been shown that L-TC of a few strains of serotype C and D has poor 
hemagglutination activity despite possessing HA proteins. Sagane et al. (2001) 
demonstrated that hemagglutination activity of serotype C strain Yoichi (C-Yoichi) was 
much lower than that of the reference serotype C strains. They analyzed N- and 
C-terminal sequence of HA-33 and found a deletion of 31 amino acid residues from the 
C-terminus at a specific site. Furthermore, when compared with a reference serotype C 
strain, the C-Yoichi HA-33 (HA-33/C-Yoichi) showed 46% amino acid identity with 76 
amino acid substitutions in the C-terminal region (residues 146-285). A recent study 
reported that C-Yoichi L-TC (L-TC/C-Yoichi) showed full HA and binding activity 
towards neuraminidase treated erythrocytes that were completely inhibited in the 
presence of galactose or lactose (Matsuo et al. 2011). Furthermore, the HA-33/HA-17 
trimer isolated from L-TC/C-Yoichi bound to neuraminidase-treated cells and the 
binding was inhibited in the presence of galactose or lactose. Thus HA-33/C-Yoichi 
dominantly recognizes galactose moiety like HA-33/A and B, even though the most 
serotype C strains preferentially interact with sialic acid moiety.  
Although it is likely that the unusual recognition of the galactose moiety of 
HA-33/C-Yoichi could be due to a variation and/or a truncation in the C-terminal-half of 
the protein, the mechanism by which this protein recognizes galactose unlike other 
serotype C strains is still unknown. The understanding of this mechanism may help the 
elucidation of pathogenesis of food borne botulism in human and animals. In this study, 
the author focused on the structure of HA-33/C-Yoichi and investigated its unique sugar 
recognition mechanism. This thesis consists of three chapters.  
In the Chapter I, the author investigated the binding of HA-33/C-Yoichi to several 
types of cells to confirm the HA-33/C-Yoichi interacts with cells by recognizing not 
7 
 
sialic acid but galactose. In the Chapter II the author attempted crystallization of 
HA-33/C-Yoichi to perform X-ray analysis. In the Chapter III, 3D structures of 
HA-33/C-Yoichi and reference strain in a crystal and solution were determined to 
distinguish the characteristic structure of HA-33/C-Yoichi. Finally, the specific site 
responsible for the carbohydrate recognition of HA-33/C-Yoichi was predicted based on 
the arrangement of amino acids in 3D structure. 
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Chapter I 
Host-cell and sugar-binding specificity of HA-33 from 
Clostridium botulinum serotype C strain Yoichi 
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1. Intorduction 
Botulinum neurotoxin (BoNT) causes flaccid muscle paralysis in humans and 
animals by inhibiting neurotransmitter release at nerve endings. Epidemiological studies 
have shown that BoNT serotypes A, B, E and F cause human botulism, whereas 
serotypes C and D appear to be causative toxins for animal and avian botulism 
(Montecucco and Schiavo 1993). In naturally contaminated foods, BoNT (150 kDa) 
associates with non- toxic non-hemagglutinin (NTNHA; 130 kDa) and three types of 
hemagglutinin (HA-70, HA-33 and HA-17; 70, 33 and 17 kDa, respectively), forming a 
large toxin complex (L-TC; 750 kDa) (Hasegawa et al. 2007; Inoue et al. 1993). The 
first step in foodborne botulism is the trafficking of L-TC from the intestinal epithelial 
cells to the bloodstream (Sakaguchi et al. 1983). 
A recent study showed that L-TC has a unique ellipsoidal-shaped structure with 
three extended “arms” of the HA-33/HA-17 (2:1) trimer and that two HA-33 molecules 
were located at the outermost region of each arm of D-4947 L-TC (Hasegawa et al. 
2007). Accordingly, HA-33 is likely to have important roles in the interaction between 
toxin and the cells. In fact, previous studies have shown that HA-33 contributes to the 
binding of L-TC to intestinal cells by recognizing carbohydrate residues on the cell 
surface. On the other hand, types of carbohydrates recognized by HA-33 molecule differ 
depending on serotypes of toxin. In general, HA-33/A and B preferentially recognizes 
galactose, whereas type C and D predominantly bind to sialic acid. HA-33/C-Yoichi, 
however, has been shown to have unique properties as to sugar recognition. Matsuo et 
al. (2011) demonstrated that C-Yoichi HA-33/HA-17 trimer bound to 
neuraminidase-treated cells and the binding was inhibited in the presence of galactose 
using a cultured rat intestinal cell line IEC-6. Although these results suggest that 
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HA-33/C-Yoichi dominantly recognizes galactose moiety on IEC-6 unlike HA-33 of 
major strain C, it is unknown whether this is the case in other types of epithelial cells.  
Accordingly, in this chapter the author investigated the binding of HA-33/C-Yoichi 
to several types of epithelial cells to confirm that HA-33/C-Yoichi generally recognizes 
galactose moiety on the cells.  
 
2. Material and methods 
2.1 Production and puriﬁcation of botulinum L-TC and isolation of HA-33/HA-17  
trimer 
C. botulinum serotype C strains Yoichi (C-Yoichi) and Stockholm (C-St) were 
cultured using a dialysis method reported previously (Miyata et al. 2012). The L-TC in 
the culture supernatants was precipitate with 60% saturation of ammonium sulfate. The 
precipitate was dialyzed against 50 mM acetate buffer (pH 4.0) with 0.2 M NaCl and 
applied to a TOYOPEARL SP-650S (Tosoh, Tokyo, Japan) equilibrated with dialysis 
buffer. Bound protein was eluted with a liner gradient of NaCl (0.2 - 0.8 M). The elution 
fraction containing the L-TC, judged by SDS- and Native- PAGE, was collected, 
concentrated with 80% saturation of ammonium sulfate and further purified with a 
HiLoad 16/60 Superdex 200 pg (GE Healthcare, Little Chalfont, UL) equilibrated with 
50 mM acetate buffer (pH 5.0) with 0.15 M NaCl, The elution fraction containing the 
L-TC was precipitated with 80% saturation of ammonium sulfate. 
Isolation of the HA-33/HA-17 trimer from the L-TC was performed as previously 
reported (Kouguchi et al. 2002). The purified L-TC (250 mg) was incubated in 20 mM 
Tris-HCl (pH 7.8) containing 4.0 M guanidine hydrochloride (Gdn buffer) at 21°C for 4 
h. Treated sample was applied to a HiLoad Superdex 200 pg 16/60 gel-ﬁltration column 
11 
 
equilibrated with the Gdn buffer. The fraction containing HA-33/HA-17 trimer was 
collected, diluted to 0.05 absorbance at 280 nm with Gdn buffer and then dialyzed 
against 20 mM Tris–HCl (pH 7.8) at 4°C and then applied to a Mono S HR 5/5 (GE 
Healthcare) with elution by a liner gradient of NaCl (0 - 0.5 M). 
 
2.2 Cell culture 
The rat small intestine epithelial cell line IEC-6 and the human colon carcinoma 
Caco-2 were obtained from RIKEN BioResouse Center (Tsukuba, Japan). The bovine 
aortic endothelial cell line (BAEC) was obtained from Cell Applications Inc. (San 
Diego, CA, USA). IEC-6 cells were grown in Dulbecco’s modified Eagle medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 
IU/ml) and streptomycin (100 μg/ml). When Caco-2 cells were cultivated, the medium 
was additionally supplemented with MEM non-essential amino acid solution. BAEC 
were cultured with bovine endothelial cell growth medium obtained from Cell 
Applications Inc. Cells were maintained in a humidified environment of 5% CO2 at 
37˚C. The culture medium was renewed every 2 - 3 days. 
 
2.3 Antibodies 
The rabbit polyclonal antibodies recognizing HA-33 was used (Niwa et al. 2010). 
 
2.4 Toxin binding assay 
The binding of C-Yoichi and C-St HA-33/HA-17 trimer to IEC-6, Caco-2 and 
BAEC cells were assayed, as described previously (Niwa et al. 2007) with minor 
modifications. Cells were prepared in 24 well dishes (Corning, Corning, NY) and grown 
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to confluence. HA-33/HA-17 trimer was suspended in 300 μl of DMEM at the indicated 
concentrations and added to culture dishes at 4°C. Cells were then incubated for 30 min 
at 4°C, rinsed three times with cold PBS and lysed with 150 μl SDS buffer. Proteins 
bound to cells in 15 μl of the sample were separated on SDS-PAGE and detected by 
Western blot analysis. 
 
2.5 Western blot 
Samples from the binding assay were electrophoresed on 13.6% SDS gels. The 
separated proteins were blotted onto a nitrocellulose membrane (GE Healthcare) and 
incubated with antibodies diluted 1 : 1000 in TBST (20 mM Tris-HCl buffer, pH 7.5, 
150 mM NaCl, and 0.1% Tween) with 5% skimmed milk at 4°C overnight. After rinsing 
three times with TBST, the membrane was incubated with horseradish peroxidase 
(HRP)-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, Dallas, TX) diluted 
1 : 1000 in TBST containing 5% skimmed milk for 1 h at room temperature. After 
rinsing, proteins were visualized by chemiluminescence detection. Goat anti-actin 
antibody and donkey anti-goat IgG antibody conjugated with HRP (Santa Cruz 
Biotechnology) were used to detect actin. The intensity of detected bands was analyzed 
with Image J 1.38 v software (http://rsb.info.nih.gov/ij/). The intensity of the band 
corresponding to HA-33 was divided by that to actin to express the normalized values 
of HA-33 binding.  
 
3. Results and discussion 
To compare the binding properties of HA-33/C-Yoichi and reference strain to cells, 
HA-33/HA-17 trimer of each strain at the same concentration was incubated with three 
13 
 
kinds of epithelial cells: rat intestinal epithelial cells, human colon carcinoma cells, and 
bovine aortic endothelial cells. Fig. 1 shows the binding amount of HA-33/HA-17 
trimer to each cell cultured in 24 well culture plates. The binding of C-Yoichi 
HA-33/HA-17 trimer to IEC-6 cells was about 30% of that of C-St. Matsuo et al., 
(2011) reported a similar observation that binding of L-TC/C-Yoichi was very smaller 
than that of C-St using horse erythrocytes. By contrast, C-Yoichi HA-33/HA-17 trimer 
showed a larger binding to Caco-2 cells than C-St: The binding of C-Yoichi 
HA-33/HA-17 trimer was about 170% of that of C-St. Furthermore, HA-33/HA-17 
tirimer of both C-Yoichi and C-St bound to BAEC to the same extent. These results 
indicate that the mechanism for the interaction of HA-33/C-Yoichi with epithelial cells 
is distinct from that of C-St.  
To investigate whether the difference in the binding property of HA-33/HA-17 
trimer between C-Yoichi and C-St is due to sugar chains on the cell surface, the binding 
of the trimer to neuraminidase-treated cells were examined. Fig 2 shows the effects of 
neuraminidase at several concentrations on the binding of HA-33/HA-17 trimer in 
IEC-6 cells. The binding of C-St HA-33/HA-17 trimer was abrogated depending on the 
concentration of neuraminidase, suggesting that the binding was mediated via sialic acid. 
On the other hand, neuraminidase treatment increased the binding of C-Yoichi 
HA-33/HA-17 trimer in a concentration-dependent manner. These results suggest that 
the sugar recognized by HA-33/C-Yoichi dominantly is not sialic acid.  
The present results suggested that HA-33/C-Yoichi recognizes not sialic acid but 
galactose in different types of epithelial cells, i. e. rat intestinal cells and bovine aortic 
endothelial cells. Additionally, a previous report showed that HA-33/C-Yoichi 
recognizes galactose on horse erythrocytes (Matsuo et al. 2011). Thus it is strongly 
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suggested that HA-33/C-Yoichi generally interacts with any types of cells by 
recognizing galactose. The difference in the binding ratio of C-Yoichi and C-St 
HA-33/HA-17 trimer among cell types may be due to a variation of carbohydrates 
expressed on the cells, although the author did not determine the kind of carbohydrate in 
the present study. It has been reported that sugar chains are differentially expressed in 
cells and are subject to change during development, differentiation, and oncogenic 
transformation and that the terminal glycosylation sequences produced by a cell are 
presumed to reflect the expression of the corresponding glycosyltransferases. (Paulson 
and Colley 1989). To understand the mechanisms underlying the interaction between 
HA-33/C-Yoichi and epithelial cells more precisely, analysis of carbohydrate on the 
surface of cells exploited in this study may be required.  
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Fig. 1. Binding amount of C-Yoichi and C-Stockholm HA-33/HA-17 trimer on 
IEC-6, Caco-2 and BAEC cells. Cells were incubated with both C-Yoichi and C-St 
HA-33/HA-17 trimer for 30 min at 4˚C. The cell lysates were applied to SDS-PAGE 
and bands were detected by a Western blot immunostaining and quantiﬁed by 
densitometric tracing as described in Materials and methods. Experiments were repeated 
in triplicate, and error bars represent the SE of the mean. 
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Fig. 2. Binding amount of -Yoichi and C-St HA-33/HA-17 trimer on 
neuraminidase-treated IEC-6 and BAEC cells. IEC-6 and BAEC Cells were 
pretreated with the indicated concentrations of neuraminidase for 18 h at 37˚C in a CO2 
incubator and then incubated with either C-Yoichi HA-33/HA-17 trimer (A and C) or 
C-St HA-33/HA-17 trimer (B and D) for 30 min at 4˚C. The cell lysates were applied to 
SDS-PAGE and bands were detected by a Western blot immunostaining and quantiﬁed 
by densitometric tracing as described in Materials and methods. Experiments were 
repeated in triplicate, and error bars represent the SE of the mean. 
  
C-Yoichi C-St 
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Summary 
In this chapter the author investigated the binding of HA-33/C-Yoichi and 
reference strain C-St to several types of epithelial cells to confirm that HA-33/C-Yoichi 
generally recognizes galactose moiety on the cells. The binding of HA-33/C-Yoichi and 
C-St to cultured epithelial cells including a rat intestinal cell line (IEC-6), bovine aortic 
endothelial cells (BAEC) and human coron carcinoma (Caco-2) was examined. The 
cells were incubated with HA-33/HA-17 trimer in a CO2 incubator for 30 min at 4℃, 
and the toxin bound to the cells were detected by Western blot using an antibody against 
HA-33. HA-33/HA-17 trimer of both C-Yoichi and C-St bound to IEC-6 cells with 
C-Yoichi HA-33/HA-17 trimer exhibiting larger binding. When sialic acid residues 
were removed from the surface of IEC-6 cells by neuraminidase treatment, the binding 
of C-St HA-33/HA-17 trimer was decreased dependent on neuraminidase 
concentrations. In contrast, neuraminidase treatment of the cells largely enhanced the 
binding of C-Yoichi HA-33/HA-17 trimer, suggesting that C-Yoichi HA-33/HA-17 
trimer did not recognize sialic acid. The binding amount of C-Yoichi HA-33/HA-17 
trimer was larger than that of C-St in Caco-2 cells, whereas HA-33/HA-17 of both 
C-Yoichi and C-St bound to BAEC to almost the same extent. Thus it is strongly 
suggested that HA-33/C-Yoichi generally interact with any types of cells by recognizing 
galactose. 
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Chapter II. 
Crystallization and preliminary X-ray analysis of HA-33 from 
Clostridium botulinum serotype C strain Yoichi 
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1. Introduction 
The botulinum toxin complex (TC), produced by the anaerobic Gram-positive 
bacterium Clostridium botulinum, causes food borne botulism. The TC is composed of 
the botulinum neurotoxin (BoNT; 150 kDa) and nontoxic proteins including nontoxic 
nonhemagglutinin (NTNHA; 130 kDa) and three types of hemagglutinin (HA) (HA-70, 
HA-33, and HA-17; 70, 33, and 17 kDa, respectively). BoNT is serologically classified 
into seven serotypes, A–G, and these are also used as descriptors of bacterial strains. 
Human botulism is caused predominantly by serotypes A, B, E and F and animal and 
avian botulism by serotypes C and D.  
After ingestion of food contaminated with the TC, the complex is exposed to acidic 
(pH 2) gastric juices, containing pepsin, in the stomach, and to several other proteases in 
the intestine. Despite such challenges, BoNT and other nontoxic components can 
nevertheless be detected in blood, wherein BoNT becomes detached from the other 
peptides and reaches neuromuscular junctions. BoNT is next internalized by nerve 
endings and cleaves specific sites in target proteins, inhibiting neurotransmitter release 
(Montecucco and Schiavo 1993). BoNT alone is easily degraded into short peptides 
when exposed to digestive enzymes of the stomach and intestine. Thus, the NTNHAs 
and HAs attached to BoNT are thought to function as delivery vehicles for BoNT 
(Miyata et al. 2009). 
The first event in food-borne botulism is toxin absorption by the upper small 
intestine. It has been reported that L-TC binds and passes through intestinal epithelial 
monolayers much more efficiently than does BoNT, because HA-33 binds to cells with 
high affinity (Niwa et al. 2007; Ito et al. 2011). Thus, HA-33 is thought to play an 
important role in binding of the TC to intestinal epithelial cells.  
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Fujinaga et al. (2000) showed that HA-33/A bound to intestinal microvilli of 
guinea pig upper small intestinal sections and that binding was inhibited by addition of 
lactose or galactose, but not by removal of sialic acid moieties by neuraminidase. 
Kojima et al. (2005) reported similar results. Thus, binding of L-TC/A to the human 
intestinal cell line Intestine-407 was inhibited by N-acetyllactosamine, lactose, and 
galactose, but not by N-acetylneuraminic acid. These results suggested that L-TC and 
HA-33/A preferentially bound to galactose. On the other hand, it has been reported that 
binding of L-TC and HA-33/D to the mouse intestinal cell line IEC-6 was inhibited by 
N-acetylneuraminic acid but not by either galactose or lactose (Niwa et al. 2010). 
Inhibition of L-TC and HA-33/C binding by N-acetylneuraminic acid has also been 
reported. Thus, it appears that HA-33/C and D bind preferentially to sialic acid (Inui et 
al. 2010). The specificities of binding of HA-33 to sugars thus differ, depending on the 
toxin serotype. HA-33/A predominantly recognizes galactose whereas HA-33/C and D 
predominantly recognize sialic acid.   
Recently, Matsuo et al. (2011) showed that HA-33/C-Yoichi exhibits a unique 
property in terms of sugar recognition. Binding of C-Yoichi L-TC (L-TC/C-Yoichi) to 
erythrocytes and IEC-6 cells was only about 10% that of the L-TC of the Stockholm 
serotype C strain (L-TC/C-St). However, when the cells were treated with 
neuraminidase, binding of L-TC/C-St fell whereas that of L-TC/C-Yoichi increased. 
These changes were sensitive to the neuraminidase concentration. Further, binding of 
the HA-33/HA-17 trimer to neuraminidase-treated IEC-6 cells fell upon addition of 
galactose and lactose, suggesting that HA-33/C-Yoichi preferentially recognizes 
galactose, in contrast to the HA-33 of C-St or D-4947. 
To date, the crystal structures of HA-33/C and the serotype D HA-33/HA-17 trimer 
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have been determined (Inoue et al. 2003; Hasegawa et al. 2007); both recognize sialic 
acid preferentially. Additionally, the crystal structure of HA-33/A (preferentially 
recognizing galactose) is available (Arndt et al. 2005). However, the structure of 
HA-33/C-Yoichi, which (uniquely) preferentially recognizes galactose, although 
belonging to serotype C, has never been determined. Herein, the author describes the 
crystallization of, and give preliminary X-ray diffraction data on, HA-33/C-Yoichi.  
 
2. Materials and methods 
2.1 Production and purification of HA-33/C-Yoichi 
The C-Yoichi ha-33 gene (AB061780) sequence (857 bp) was amplified by PCR 
using genomic DNA as a template. The primers were: forward 
5′-CACCATGTCTCAAACAAATG-3′ and reverse 
5′-TTATAATCTTGTTATAATCCATTTTGTGC-3′. The PCR product encoding the 
ha-33 gene was cloned into the pET200/D-TOPO plasmid vector, and the recombinant 
plasmid transformed into Escherichia coli TOP 10. Transformants were selected on LB 
plates with 50 µg/ml kanamycin, and plasmid DNA was extracted using a QIAprep Spin 
Miniprep kit (Qiagen, Dusseldorf, Germany). Sequencing was performed with the aid of 
vector-specific primers. Extension products were dye-labelled using an ABI PRISM Big 
Dye Terminator kit (Applied Biosystems, Carlsbad, CA) and sequenced on a Model 
3130 DNA platform (Applied Biosystems). The pET200/D-TOPO-ha-33 construct (10 
ng) was next transformed into E. coli BL21-star (DE-3) cells for production of 
recombinant HA-33 (rHA-33). E. coli was inoculated into 10 ml of LB broth with 100 
µg/ml kanamycin and grown overnight (18 h) at 37°C, with gentle shaking. This culture 
was inoculated into 400 ml of LB broth and incubated at 37°C until mid-log phase was 
22 
 
attained (the OD600 was about 0.5). Isopropyl-β-D-thiogalactoside (IPTG) was added to 
a final concentration of 0.1 mM and induction proceeded at 18°C for a further 18 h. 
Harvested cells were suspended in 40 ml of 50 mM phosphate buffer (pH 7.4) with 0.3 
M NaCl, sonicated, and centrifuged at 10,000 g for 20 min at 4°C. The supernatant was 
mixed with 5 ml of a 50% (w/v) Ni-charged Resin (Bio-Rad, Hercules, CA) suspension 
equilibrated with the same buffer and the mixture was poured into a glass column. After 
washing, the bound protein was eluted in equilibration buffer with 300 mM imidazole. 
rHA-33 was precipitated by addition of ammonium sulfate at 80% saturation. The 
precipitate was dialyzed against 50 mM phosphate buffer (pH 6.0) with 0.15 M NaCl 
and finally subjected to gel filtration on a Superdex 200 HR 16/60 (GE Healthcare) 
column equilibrated with the same buffer. 
 
2.2 Crystallization and X-ray data collection 
Crystals were grown at 20°C by the hanging-drop vapor-diffusion method (Adachi 
et al. 2003). A protein solution was concentrated to minimal volume using Amicon 
Ultara-0.5 filtration (molecular weight cut-off: 10 kDa; Millipore, Concord Road 
Billerica, MA) and diluted to 5.0 mg/ml in 50 mM acetate buffer (pH 5.0) in the 
absence of any other salt. This solution was filtered through an Ultrafree-MC (0.22 µm 
in pore diameter; Millipore, Concord Road Billerica, MA). Initial crystallization 
screening was performed using the Crystal Screen (Hampton Research, Aliso Viejo, 
CA). Each reservoir solution (500 µl) was transferred to a VDX plate (Hampton 
Research), crystallization drops were added, and the wells individually sealed with 
coverslips. Crystals were flash-cooled in a stream of gaseous nitrogen at -173.15°C in 
the presence of a cryoprotectant [30% (w/v) polyethylene glycol 400, in 0.1 M Tris 
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buffer (pH 8.5)]. Diffraction data were collected using beamline AR-NW12A, fitted 
with an ADSC quantum 210r CCD detector (Photon Factory, Tsukuba, Japan), and 
processed using HKL2000 software (Otwinowski and Minor 1997). 
 
3. Results and discussion 
The serotype C HA-33 protein of C-St was earlier crystallized and the structure 
determined (Nakamura et al. 2007). However, the extent of amino acid sequence 
identity between the HA-33 of C-Yoichi and C-St is only 73.4%, and falls to 46.1% in 
the C-terminal halves of the proteins (Sagane et al. 2001). The HA-33/C-Yoichi 
recognizes galactose-terminated sugar chains on the cell surface, whereas most serotype 
C strains recognize sialic acid-terminated chains. Thus, the HA-33/C-Yoichi is atypical. 
The HA-33/A recognizes principally galactose moieties, as does HA-33/C-Yoichi. 
However the amino acid sequences of serotypes A and C-Yoichi are only 35.8% 
identical. Therefore, it may be that the HA-33/C is novel. We therefore cloned and 
crystallized the HA-33/C-Yoichi, and obtained preliminary structural data.  
As shown in Fig. 1, highly purified rHA-33 ran as a single band on SDS-PAGE, 
and had a molecular mass of 37 kDa, as expected from addition of the estimated 
molecular mass of HA-33 and that of the N-terminal His-Tag. One early report 
suggested that the HA-33/C-Yoichi was cleaved in the C-terminal region, in an 
unknown manner, increasing mobility on SDS-PAGE (Sagane et al. 2001). In the 
present study, we found no evidence of such cleavage, and concluded that recombinant 
protein produced in E. coli was not in fact cleaved. We crystallized the protein.   
When incubated in drops consisting of 3.0 µl of protein solution and 2.0 µl of a 
crystallization reservoir solution with 8% (w/v) polyethylene glycol 8000 and 5% (w/v) 
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polyethylene glycol 400, in 0.1 M Tris buffer at pH 8.5, two types of crystals appeared 
within 3 days of incubation and grew to maximum dimensions of 0.05 x 0.05 x 0.1 mm 
[crystal (a) of Fig. 2] and 0.01 x 0.01 x 0.2 mm [crystal (b) of Fig. 2]. Diffraction data 
were obtained from the later crystals under cryo-conditions; a full set of intensity data 
was collected at a resolution of 2.2 Å (Fig. 3). The other type of crystal did not yield 
diffraction data. Data collection statistics and crystal data are summarized in Table 1. In 
this experiment more exposure time than as usual was needed because of beamline 
trouble. Two molecules formed an asymmetric unit, as was also true of crystals of 
HA-33/C-St (Inoue et al. 2003). Determination of the complete structure of the unique 
HA-33/C-Yoichi may help us to understand how L-TC is absorbed from the intestine. It 
will be useful to understand how the novel HA subunit of the TC of C. botulinum binds 
to the cell. 
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Table 1 Data collection statistics. 
Values in parentheses represent those of the shell of highest resolution.                                                              
 Crystal to film distance (mm) 212.4  
 Exposure time (sec) 5  
 Oscillation angle (degree) 1 
 Wavelength (Å)  1.000 
 Temperature (K)    100 
 Resolution (Å)   50 – 2.2 (2.24 – 2.2) 
 No. of unique reflections  48,719 
 Redundancy        2.9 (2.8) 
 Completeness (%)    100 (99.8) 
 Rmerge †       0.085 (0.461) 
  I/(I)      15.5 (2.8) 
 Space group     R3 
 Unit-cell parameters 
     a = b, c (Å)      142.52, 126.79  
 = ,  (°)     90, 120 
                                                            
† Rmerge = Σhkl Σi ｜ Ii(hkl) —〈I(hkl)〉｜／Σhkl Σi Ii (hkl), where 〈I(hkl)〉 is the mean 
intensity of multiple observations of symmetry-related reflections. 
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Fig. 1. SDS–PAGE of purified rHA-33. The sizes of molecular weight markers, in 
kDa, are marked on the left. Lane 1, molecular weight standard; lane 2, purified 
rHA-33. 
 
 
  
27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Two types of rHA-33 crystals grown using the hanging-drop vapor-diffusion 
method. The average dimensions of the crystals were 0.05 x 0.05 x 0.1 mm (a) and 0.01 
x 0.01 x 0.2 mm (b). The later crystals were used to obtain X-ray diffraction data. Scale 
bar: 0.1 mm. 
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Fig. 3. An X-ray diffraction image from a rHA-33 crystal. The edge of the detector 
corresponds to a resolution of 2.2 Å.  
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Summary 
In this chapter the author performed crystallization and X-ray analysis of 
HA-33/C-Yoichi that recognizes galactose unlike major serotype C strains. The 
C-Yoichi ha-33 gene (AB061780) sequence (857 bp) was amplified by PCR and was 
cloned into Escherichia coli TOP 10. The gene was transformed into E. coli BL21 Star 
(DE-3) cells, and E. coli culture supernatant was applied for column chromatography 
for the production of recombinant HA-33 (rHA-33). Crystallization of rHA-33 was 
attempted under 286 patterns with various conditions including temperature, protein 
concentration, precipitation drug and buffer in reservoir solution by hanging drop 
method. When incubated in drops comprised of 3.0 µl protein solution and 2.0 µl 
crystallization reservoir solution consisting of 8% (w/v) polyethylene glycol 8000 in 0.1 
M Tris buffer pH 8.5, crystals appeared within 3 d of incubation and grew to maximum 
dimensions of 0.01 x 0.01 x 0.2 mm. Thus the author succeeded in producing a crystal 
of C-Yoichi HA-33, which is available for X-ray analysis, for the first time. X-ray 
analysis of the crystal with beamline AR-NW12A fitted with an ADSC Quantum 210r 
CCD detector (Photon Factory, Tsukuba, Japan) demonstrated that a resolution was 2.2 
Å, and the crystal belonged to space group R3 with Unit-cell parameters of a = b = 
142.52 Å and c = 126.79 Å. 
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Chapter III 
Determination of 3D structure and prediction of 
sugar-binding sites of HA-33 from Clostridium botulinum 
serotype C strain Yoichi 
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Chapter III-1 
The solution structures of HA-33 from 
 Clostridium botulinum serotype D strain 4947 
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1. Introduction 
Botulinum toxin complex (TC), which is produced by the anaerobic gram-positive 
bacterium Clostridium botulinum, is the causative agent of food-borne botulism. The TC 
is composed of the botulinum neurotoxin (BoNT; 150 kDa) and auxiliary nontoxic 
proteins. C. botulinum is classified into seven serotypes, A–G, based on the antigenicity 
of the BoNT. Human botulism is caused predominantly by serotypes A, B, E and F 
while animal and avian botulism is due to the serotypes C and D (Montecucco and 
Schiavo 1994; Li and Singh 1999). Orally ingested TC passes through the digestive tract 
and enters the blood stream via the intestinal wall. Once in the blood stream BoNT 
dissociates from the TC then reaches and penetrates into the nerve cells of the 
neuromuscular junction, where it cleaves a specific site on the protein involved in 
neurotransmitter release resulting in paralysis of the muscle. The auxiliary nontoxic 
proteins of the TC include nontoxic nonhemagglutinin (NTNHA; 130 kDa) and three 
types of hemagglutinin (HA) components with molecular masses of 70, 33 and 17 kDa 
(HA-70, HA-33 and HA-17, respectively). The TC assembly includes association of a 
single BoNT and a single NTNHA to form M-TC, which is amazingly stable in the 
acidic and proteolytic conditions of the digestive tract (Miyata et al. 2009). Further 
binding of three HA-70 proteins onto the M-TC yields M-TC/HA-70. Finally, 
attachment of three HA-33/HA-17 trimers, each of which are comprised of a single 
HA-17 and two HA-33 proteins, to M-TC/HA-70 via binding of HA-70 and HA-17 
results in forming the 14-mer mature L-TC. In addition, there are intermediate L-TC 
species having fewer HA-33/HA-17 trimers in the culture supernatant of C. botulinum 
(Mutoh et al. 2003). 
Generally, the physical barrier presented by the intestinal wall prevents the 
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entrance of macromolecules such as proteins into the body. All the TCs, however, 
produced by D-4947, including pure BoNT, M-TC, M-TC/HA-70 and L-TC, can be 
transported across a rat intestinal epithelial cell (IEC-6) monolayer (Ito et al. 2011). 
Additionally, transport of the toxins is enhanced depending on the number of 
HA-33/HA-17 trimers. Similar to the TC species, the HA-33/HA-17 trimer isolated 
from the L-TC/D-4947 can also be transported across the IEC-6 cell layer (Niwa et al. 
2010). Therefore, the HA-33/HA-17 trimer plays an important role in the effective 
transport of toxin across the intestinal wall.  
Hasegawa et al. (2007) demonstrated the crystal structure of D-4947 
HA-33/HA-17 trimer (HA-33/HA-17 trimer/D-4947). Although the analysis of crystal 
structure of protein provides information as to a spatial arrangement of amino acids of 
each domain, the structure in crystal may not be regarded as native appearance because 
protein complex functions in a solution in biological conditions. In fact, the interaction 
of HA-33 and carbohydrate on cell surface occurs in the intestinal fluid. Thus, analysis 
of crystal structure and solution structure of HA-33 may provide important information 
as to the difference of sugar recognition between reference strain and C-Yoichi.  
In the Chapter III, 3D structure of HA-33/C-Yoichi was analyzed to clarify the 
molecular basis of galactose-recognition. In the first section the author attempted to 
clarify and compare the crystal and solution structures of HA-33. At first, the solution 
structure of reference strain HA-33/D-4947 was determined using small-angle X-ray 
scattering (SAXS) analysis, and was compared with crystal structure that has already 
been established. Furthermore, the solution structure of the HA-33/HA-17 trimer was 
investigated in the absence and presence of the sugars N-acetylneuraminic acid, glucose 
and galactose to know HA-33/HA-17 trimer shows any conformational change by 
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binding to sugars.  
 
2. Material and methods 
2.1. Production and purification of botulinum TC 
C. botulinum D-4947 was cultured using a dialysis method as described 
previously (Miyata et al. 2012). The TC in the culture supernatant was precipitated with 
60% saturation of ammonium sulfate. The resultant precipitate was dissolved and 
dialyzed against 50 mM acetate buffer (pH 4.0) with 0.2 M NaCl and applied to a 
TOYOPEARL SP-650S (Tosoh) cation-exchange column (1.6 x 40 cm) equilibrated 
with dialysis buffer. Bound protein was eluted with a linear gradient of NaCl (0.2–0.8 
M). The peak fraction containing the L-TC, judged by SDS- and native-PAGE, was 
collected, concentrated and further purified with a HiLoad 16/60 Superdex 200 pg (GE 
Healthcare) equilibrated with 50 mM acetate buffer (pH 5.0) with 0.15 M NaCl. The 
peak fraction containing the L-TC was precipitated with 80% saturation of ammonium 
sulfate. 
 
2.2. Isolation of the HA-33/HA-17 trimer from the L-TC 
Isolation of the HA-33/HA-17 trimer from the L-TC was performed as previously 
reported (Kouguchi et al. 2002). The concentrated L-TC, in a 250 mg precipitate pellet, 
was dissolved in 0.7 ml of 20 mM Tris-HCl (pH 7.8) containing 4 M guanidine 
hydrochloride (Gdn buffer) and incubated at 21°C for 4 h. Treated sample was applied 
to a HiLoad Superdex 200 pg 16/60 gel-filtration column equilibrated with the Gdn 
buffer. The fraction containing HA-33/HA-17 trimer was collected, diluted to 0.1 
absorbance at 280 nm with Gdn buffer, and then dialyzed against 20 mM Tris-HCl (pH 
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7.8) at 4°C for 15 h to remove the guanidine hydrochloride. 
 
2.3. PAGE analysis 
SDS–PAGE was performed as described by Laemmli (Laemmli 1970) using a 
13.6% polyacrylamide gel in the presence of 2-mercaptoethanol. Native PAGE was 
carried out using the method of Davis (1964) at pH 8.8 using a 5-12.5% polyacrylamide 
linear gradient gel. The separated peptides were stained with Coomassie Brilliant Blue 
R-250. 
 
2.4. Small-angle X-ray scattering analysis 
Small-angle X-ray scattering (SAXS) measurements of the HA-33/HA-17 trimer in 
20 mM Tris–HCl (pH 7.8) were performed on a Rigaku BioSAXS-1000 using 10 - 20µl 
of protein solution. A total of eight datasets were collected after 120 min exposure (15 
min per data set). Raw data were analyzed using the SAXSLab software package 
(Rigaku, Tokyo, Japan). SAXS curves were generated after subtracting the scattering 
due to the solvent in the protein solution, using the program PRIMUS from the ATSAS 
package 
 
3. Results  
HA-33/HA-17 trimer was purified from L-TC produced by C. botulinum D-4947 
in the presence of guanidine hydrochloride. The purified HA-33/HA-17 trimer 
displayed two bands in SDS–PAGE with molecular masses of 33 and 17 kDa (Fig. 1B). 
The crystal structure of the D-4947 HA-33/HA-17 trimer was previously determined 
and revealed an isosceles triangle-like structure in which one end of each of two 
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ellipsoidal HA-33 molecules is attached to a sphere-shaped HA-17 molecule (Fig. 1C) 
(Hasegawa et al. 2007). After removal of the guanidine hydrochloride, the 
HA-33/HA-17 trimer was subjected to SAXS analysis and the dummy atom model 
(DAM) was generated (Fig. 2). The SAXS-derived DAM image also indicated that the 
HA-33/HA-17 trimer forms an isosceles triangle-like structure but kinked at the middle 
of the triangle. Further, the SAXS DAM image is slightly larger than that seen in the 
crystallographic image as shown in the right panel of Fig. 2. Therefore the junction 
between the single HA-17 and dual HA-33 molecules would be flexible allowing 
iterative hinge-like movement of the trimer from flat to a kinked triangle as shown in 
the middle panel of Fig. 2.  
Fig. 3 shows the SAXS DAM images of the HA-33/HA-17 trimer in the presence 
of 1 mM of Neu5Ac, glucose and galactose. All the images in the presence of sugars 
displayed similar appearance, with a more elongated shape than that seen in the absence 
of the sugars. As shown in the rightmost panel of Fig. 3, a single HA-17 and two HA-33 
molecules were superimposed into the SAXS DAM image manually, so that all 
molecules were fitted into the image. The second panel from the right of Fig. 3 contains 
the best-fit model of the HA-33/HA-17 trimer in the presence of the sugars. In the 
absence of the sugars, the dual HA-33 molecules are attached onto the single HA-17 
molecule in juxtaposition (Fig.1C and 2). In contrast, the rearranged model in the 
presence of the sugars indicates that the two HA-33 molecules are not juxtaposed, 
instead they are attached to HA-17 at a drastically increased angle of ~120° 
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4. Discussion 
In a previous report, Sagane et al., (2012) revealed the crystallographic and SAXS 
images of the NTNHA protein, another nontoxic component of the botulinum TC. By 
comparing the images, a part of the SAXS image of the NTNHA displayed a more 
extended appearance than that seen in the crystallographic image. The discrepancy 
observed in the crystallographic and SAXS images implied a high flexibility of the 
C-terminal region of the NTNHA molecule. SAXS analysis therefore would be useful to 
clarify the structural dynamics of protein in solution. In this study we revealed a 
sugar-induced structural shift of the HA-33/HA-17 trimer in solution. Sugar binding 
proteins sometimes demonstrate a conformational change induced by the presence of 
sugars, such as D-Glucose/D-Galactose binding protein (Borrok et al. 2007) and lactose 
permease (Nie and Kaback 2010).  
Previously, Nakamura et al. 2008 identified the two sugar-binding sites of the 
serotype C HA1 (our HA-33) designated as site I and II. Site I is involved in binding 
with the sugars Neu5Ac, N-acetylgalactosamine, and galactose, whereas site II binds 
only with galactose. Additionally, X-ray analysis of the HA-33/HA-17 trimer crystal 
indicated that there is a region with low electron density in the HA-17 molecule 
(Hasegawa et al. 2007), implying its structural flexibility. Therefore, binding of the 
sugars to these sites may induce a structural shift. However, the glucose-binding site in 
the HA-33 molecule has not been identified. Another possibility to explain the 
difference observed in the trimer structure in the presence and absence of sugars, is that 
one of the HA-33 molecules could transfer to an alternate binding site on HA-17 in the 
presence of sugars. RADAR (http://www.ebi.ac.uk/Tools/pfa/radar) (Heger and Holm 
2000), a program used to detect repeats in protein sequences, revealed two pairs of 
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repeat-sequences, DYG-FIYLSSSSNNSLWNPI (72–90) and 
DYAWTIYDNNNNITDQPI (109–126), and NGNYKIKSLFSDSLYLTY (10–27) and 
NGFRFSNVAEPNKYLAY (54–70), in the HA-17 molecule. The crystal structure of 
the HA-33/HA-17 trimer indicated that a set of Asp123, Pro125 and Leu127 residues in 
HA-17 is responsible for the interaction with one of the two HA-33 molecules, whereas 
the set of Asn106, Thr108, and Pro130 is involved in the binding to the other HA-33 
molecule. Most of the residues in the first set are included in Asp109–Ile126, which is 
one-half of the first pair of internal repeat sequences. Therefore the site in the other half 
of the pair, Asp72–Ile90, of HA-17 would be a candidate for the binding site for the 
HA-33, which detached from the original position of the HA-17 molecule. 
In this study, we found a sugar-induced structural shift of the HA-33/HA-17 trimer 
based on SAXS analysis. However, the physiological meaning of the structural shift 
remains unclear. Transport of botulinum TC through the intestinal epithelial cell layer is 
enhanced by the HA-33/HA-17 arm of the TC in a sialic-acid dependent manner (Ito et 
al. 2011). The structural shift of the HA-33/HA-17 arm of the TC may be induced by 
the binding of HA-33 to the sugar chain on the epithelial cell surface. This could result 
in enhancement of penetration by the TC across the cell layer. On the other hand, in the 
food-poisoning process the toxins transit the digestive tract with dietary 
macromolecules including polysaccharides. During transit, the polysaccharides would 
be degraded into monosaccharides, and such monosaccharides may affect transport of 
the botulinum toxin across the intestinal wall via the sugar-induced structural shift of 
the HA-33/HA-17 arms on the TC. In future studies, the effect of sugars on the transport 
of the TC across the intestinal epithelial cell layer should be examined to clarify the 
physiological meaning of the structural shift of the HA-33/HA-17 trimer.  
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Fig. 1. Assembly pathway of the botulinum toxin complex (TC) and 
characterization of the HA-33/HA-17 trimer used in this study.  A. Assembly 
pathway of the botulinum TC. Binding of BoNT and NTNHA yields M-TC. Attachment 
of three HA-70 components to the M-TC forms M-TC/HA-70, finally three 
HA-33/HA-17 trimers consisting of a single HA-17 and two HA-33 proteins are 
conjugated to the M-TC/HA-70, resulting in the mature L-TC. B. SDS-PAGE banding 
pattern of purified HA-33/HA-17 trimer. After purification from L-TC, HA-33/HA-17 
trimer was analyzed by SDS-PAGE using a 15 % polyacrylamide gel. The proteins in 
the gel were stained with Coomassie Brilliant Blue. The molecular masses of the protein 
standards (lane 1) are labeled on the left in kDa. The HA-33/HA-17 complex (lane 2) 
displayed two bands with molecular masses of 33 and 17 kDa. C. Surface representation 
of the D-4947 HA-33/HA-17 trimer revealed in a previous study (Hasegawa et al. 2007). 
The HA-33 and HA-17 molecules are indicated in blue and light blue, respectively. The 
left image is rotated 90˚ clockwise around the y-axis compared to the right image. 
  
40 
 
Fig. 2. Solution structure of HA-33/HA-17 trimer revealed by SAXS analysis. 
Solution structure of the HA-33/HA-17 trimer is represented by the dummy atom 
model (DAM) (left). A model of the solution structure of the HA-33/HA-17 trimer 
(center) is illustrated based on the superimposition of the SAXS image and surface 
representation image of the crystal (right). Dotted line and arrow indicate the original 
position of the dual HA-33 molecules revealed by the crystallographic image (see Fig. 
1B) and iterative movement of the molecules presumed by the SAXS DAM image, 
respectively. The HA-33 molecules in the trimer were displaced so that the crystal 
structure fits into the SAXS image.  
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Fig. 3. Solution structure of HA-33/HA17 trimer in the presence of various sugars. 
SAXS images of HA-33/HA-17 trimer in the presence of Neu5Ac, glucose and 
galactose are represented in DAM. A model of the solution structure of the trimer in 
the presence of the sugars (second panel from right) is illustrated based on the 
superimposition of the SAXS image and surface representation image of the crystal 
(rightmost panels). The HA-33 molecules in the trimer were displaced so that the 
crystal structure fits into the SAXS image as shown in the rightmost panels. 
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Summary 
In the Chapter III-1, the author determined the solution structure of HA-33/D-4947, 
which has been purified from culture supernatant of D-4947, and compared it with 
crystal structure. The HA-33/HA-17 trimer was subjected to SAXS analysis and the 
dummy atom model (DAM) was generated. The SAXS-derived DAM image indicated 
that the HA-33/HA-17 trimer forms an isosceles triangle-like structure but kinked at the 
middle of the triangle. Further, the SAXS DAM image is slightly larger than that seen in 
the crystallographic image. Therefore the junction between the single HA-17 and dual 
HA-33 molecules would be flexible allowing interactive hinge-like movement of the 
trimer from flat to a kinked triangle. In the absence of the sugars, the dual HA-33 
molecules are attached onto the single HA-17 molecule in juxtaposition. In contrast, the 
rearranged model in the presence of the sugars indicates that the two HA-33 molecules 
are not juxtaposed, instead they are attached to HA-17 at a drastically increased angle of 
~120°. 
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Chapter III-2 
The crystal and solution structures of HA-33 from Clostridium 
botulinum serotype C strain Yoichi 
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1. Introduction 
It has been shown that L-TC/C and D preferentially recognizes sialic acid on the 
cell surface via HA-33 molecule. On the other hand, unique HA-33 proteins produced 
by C-Yoichi preferentially recognizes galactose, rather than sialic acid. In the previous 
section, the three-dimensional structures for the sialic acid-binding HA-33 and D-4947 
HA-33/HA-17 trimer, a reference strains, were determined. The results indicated that 
three-dimensional structure of HA-33/HA-17 trimer/D-4947 in solution was somewhat 
larger than that in crystal. 
In this section, the author determined the three-dimensional structure of the 
galactose-binding HA-33 and HA-33/HA-17 trimer produced by the strain C-Yoichi. 
The results indicate the drastic conformational divergence between the sialic acid and 
galactose-binding HA-33/HA-17 trimers.   
 
2. Material and methods 
2.1. Production and puriﬁcation of botulinum L-TC and isolation of HA-33/HA-17  
trimer 
C. botulinum C-Yoichi was cultured using a dialysis method reported previously 
(Miyata et al. 2012).The L-TC in the culture supernatants was precipitate with 60% 
saturation of ammonium sulfate. The precipitate was dialyzed against 50 mM acetate 
buffer (pH 7.4) with 0.2 M NaCl and applied to a TOYOPEARL SP-650S (Tosoh) 
equilibrated with dialysis buffer. Bound protein was eluted with a liner gradient of NaCl 
(0.2 - 0.8 M). The elution fraction containing the L-TC, judged by SDS- and Native 
PAGE, was collected, concentrated with 80% saturation of ammonium sulfate and 
further purified with a HiLoad 16/60 Superdex 200 pg (GE Healthcare) equilibrated 
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with 50 mM acetate buffer (pH 5.0) containing 0.15 M NaCl, The elution fraction 
containing the L-TC was precipitated with 80% saturation of ammonium sulfate. 
Isolation of the HA-33/HA-17 trimer from the L-TC was performed as previously 
reported (Matsuo et al. 2011). The purified L-TC (250 mg) was incubated in 20 mM 
Tris–HCl (pH 7.8) with 4.0 M guanidine hydrochloride (Gdn buffer) at 21°C for 4 h. 
Treated sample was applied to a HiLoad Superdex 200 pg 16/60 gel-ﬁltration column 
equilibrated with the Gdn buffer. The fraction containing HA-33/HA-17 trimer was 
collected, diluted to 0.05 absorbance at 280 nm with Gdn buffer and then dialyzed 
against 20 mM Tris–HCl (pH 7.8) at 4°C and then applied to a Mono S HR 5/5 (GE 
Healthcare) with elution by a liner gradient of NaCl (0 - 0.5 M). 
 
2.2. Production and puriﬁcation of recombinant HA-33 
Production and puriﬁcation of the recombinant HA-33 (rHA-33: C-Yoichi) were 
performed using a method reported previously (Hayashi et al. 2014). E. coli BL21 cells 
harboring a pET200/D-TOPO-ha33 vector, in which the ha-33 gene is ligated 
downstream of the 6x His-tag coding sequence, were cultured in 10 ml of LB broth 
containing 100 µg/ml kanamycin at 37°C overnight with mild shaking. This culture was 
inoculated into 400 ml LB broth and incubated at 37°C until mid-log phase was attained 
(the OD 600 was about 0.5). IPTG was added to a ﬁnal concentration of 0.1 mM and 
induction proceeded at 37°C for a further 18 h. Harvested cells were suspended in 40 ml 
50 mM phosphate buffer (pH 7.4) with 0.3 M NaCl, sonicated and centrifuged at 
10,000g for 20 min at 4°C . The supernatant was mixed with 5 ml of 50% (w/v) 
Ni-charged Resin (Bio-Rad) suspension equilibrated with the same buffer and the 
mixture was poured into a glass column. After washing, the bound protein was eluted in 
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equilibration buffer with 300 mM imidazole. rHA-33 was precipitated by the addition of 
ammonium sulfate at 80% saturation. The precipitate was dialyzed against 50 mM 
phosphate buffer pH 6.0 with 0.15 M NaCl and ﬁnally subjected to gel ﬁltration on a 
Superdex 200 HR 16/60 column (GE Healthcare) equilibrated with the same buffer. The 
purity of the eluted proteins was judged by SDS–PAGE. 
 
2.3. Structural determination and crystallographic reﬁnement of rHA-33 
Crystals of the C-Yoichi HA-33 were obtained using the hanging drop vapor 
diffusion method as described previously (Hayashi et al. 2014). X-ray diffraction data 
of the C-Yoichi HA-33 was integrated and scaled using MOSFLM (Leslie and Powell 
2007) and SCALA (Evans 2006), respectively, in the CCP4 suite (Winn et al. 2011). 
The initial structure of C-Yoichi HA-33 was solved by molecular replacement using the 
program MOLREP (Vagin and Teplyakov 1997) in the CCP4 suite using the coordinates 
of D-4947 HA-33/HA-17 trimer (PDB code:2E4M) as a target model. Reﬁnements for 
structures were carried out ﬁrst with the program CNS (Brunger et al. 1998), with the 
program REFMAC5 (Murshudov et al. 1997) in the CCP4 suite. Figures were prepared 
with the Pymol. 
 
2.4. Small-angle X-ray scattering analysis 
Small-angle X-ray scattering (SAXS) measurements of the HA-33/HA-17 trimer 
(10 mg/ml) in 20 mM Tris–HCl (pH 7.8) were performed on a Rigaku BioSAXS-1000 
using 20 µl of protein solution. A total of eight datasets were collected after 120 min 
exposure (15 min per data set). Raw data were analyzed using the SAXSLab software 
package (Rigaku, Tokyo, Japan). SAXS curves were generated after subtracting the 
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scattering due to the solvent in the protein solution, using the program PRIMUS from 
the ATSAS package. 
 
3. Results and discussion 
The crystal structures of HA-33/C and D preferentially binding to the sialic acid 
have been published in the HA-33 protein from the strain C-St (Inoue et al. 2003) and 
HA-33/HA-17 trimer/D-4947 (Hasegawa et al. 2007). In this section the author 
determined the structure in crystal and solution of the HA-33/C-Yoichi to compare the 
three-dimensional structure of the sialic acid- and galactose-binding HA-33/C and D. 
The HA-33/C-Yoichi was produced as a recombinant protein in the E. coli, and 
then the crystal was obtained using the hanging drop vapor diffusion method as 
described in the chapter I. Diffraction data obtained in this report was employed from 
the determination of X-ray crystal structure of the rHA-33 at 2.2 angstrom resolution by 
molecular replacement using the HA-33 structure in HA-33/HA-17 trimer/D-4947 
(Hasegawa et al. 2007). The final model was refined to an R-factor of 19.6 % and a free 
R-factor of 22.4 %. The final model (center panel of Fig. 1) includes two protein 
molecules in the asymmetric unit, as was also true for the crystals of C-St HA-33 (left 
panel of Fig. 1). As shown in right panel of the Fig. 1, the crystal structure shows that 
the C-terminal half domain (HA-33V region) of the C-Yoichi protein warps to outside 
slightly than that of C-St protein, but drastic structural change in the crystals due to the 
amino acid replacements was not observed.  
In the previous section, the author revealed the conformational flexibility of the 
HA-33/HA-17 timier in the solution based on SAXS analyses. Thus the junction 
between the HA-33 and HA-17 molecules would be flexible allowing the hinge-like 
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movement of the trimer. A similar conformational flexibility has also been demonstrated 
in botulinum NTNHA protein (Sagane et al. 2012). Here, the author clarified the 
solution structure of HA-33/HA-17 trimer/C-Yoichi by SAXS analysis as shown in Fig. 
2. The SAXS image of HA-33/HA-17 trimer/ C-Yoichi (upper panels in Fig. 2) 
displayed more elongated shape than that seen in the D-4947 trimer (lower panels in Fig. 
2). In the Fig. 2, the crystal structures of the two HA-33 molecules and a single HA-17 
molecule were superposed into the SAXS image from the C-Yoichi and D-4947 
molecules, so that all molecules were fitted into the image. In the D-4947 molecule, 
both of two HA-33 molecules are attached onto the single HA-17 molecule in 
juxtaposition. In the C-Yoichi trimer, the HA-33 molecules are not juxtaposed on the 
HA-17.  
In conclusion, the present study revealed that the solution structure of C-Yoichi 
HA-33/HA-17 trimer is extremely different from that of major C and D trimer. A 
schematic model for comparison of 3D structure of HA-33/C-Yoichi and HA-33/C and 
D in crystal and solution is shown in Fig. 3. 
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Fig. 1. Crystal Structure of HA-33/C-St and C-Yoichi. The final model (center panel) 
includes two protein molecules in the asymmetric unit, as was also true of crystals of 
C-St HA-33 (left panel). As shown in right panel, the crystal structure shows that the 
C-terminal half domain (HA-33V region) of the C-Yoichi protein warps to outside 
slightly than that of C-St protein, but drastic structural change in the crystals due to the 
amino acid replacements was not observed.  
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Fig. 2. Superimposed of the crystal and solution structure of HA-33/HA-17 
trimer/C-Yoichi and D-4947. The SAXS image of HA-33/HA-17 trimer/C-Yoichi 
(upper panels) displayed more elongated shape than that seen in the D-4947 trimer 
(lower panels). The crystal structures of the two HA-33 molecules and a single HA-17 
molecule were superposed into the SAXS image from the C-Yoichi and D-4947 
molecules, so that all molecules were fitted into the image. 
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Fig. 3. A schematic model for comparison of 3D structure of HA-33/C-Yoichi and 
HA-33/C and D in crystal and solution 
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Summary  
In this section, the author determined 3D structure of the galactose-binding HA-33 
and HA-33/HA-17 trimer produced by the strain C-Yoichi in crystal and solution to 
compare it with sialic acid-binding HA-33 from major serotype C and D strains. X-ray 
analysis with the crystal obtained in the Chapter I showed that C-Yoichi HA-33 includes 
two protein molecules in the asymmetric unit; the C-terminal half domain the C-Yoichi 
protein warps to outside slightly than that of C-St protein, but drastic structural change 
in the crystals was not observed. When the solution structure was determined with 
SAXS, HA-33/HA-17 trimer/C-Yoichi displayed more elongated shape than that seen in 
the D-4947 trimer; In the D-4947 molecule, both of two HA-33 molecules are attached 
onto the single HA-17 molecule in juxtaposition whereas the HA-33 molecules are not 
juxtaposed on the HA-17 in C-Yoichi trimer. Thus the present study clearly revealed 
that the solution structure of HA-33/HA-17 trimer/C-Yoichi is extremely different from 
that of major C and D trimer. 
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Chapter III-3 
Prediction of sugar-binding sites of HA-33 from  
Clostridium botulinum serotype C strain Yoichi 
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1. Intorduction 
In the Chapter III-2, the author compared the crystal and solution structures of 
HA-33/HA-17 trimer/C-Yoichi and C-St or D-4947, a reference strain. The results 
showed that the angle of two HA-33 molecules in HA-33/ HA-17 trimer/C-Yoichi was 
larger than that of reference strains and the difference of the angle was obvious in 
solution than in crystal. It has been shown that, HA-33/A and B preferentially 
recognizes galactose, whereas type C and D predominantly bind to sialic acid. However, 
HA-33/C-Yoichi dominantly recognizes galactose moiety like HA-33/A and B. These 
facts raise the possibility that the structure of galactose-recognition region of 
HA-33/C-Yoichi is analogous to that of HA-33/A and B. Additionally, another 
possibility may be considered that HA-33/C-Yoichi has a particular structure for 
galactose-recognition region distinct from HA-33/A and B. 
In this section the author attempted to determine the specific site responsible for 
galactose-recognition of HA-33/C-Yoichi by comparing three-dimensional structures of 
HA-33 with in silico study.  
 
2. Material and methods 
2.1 The phylogenetic tree of C-Yoichi and the other type HA-33 
Amino acid sequences of the HA-33 proteins from serotype A, B, C, D and G 
strains were gathered from the NCBI protein database and aligned (ClustalW). To 
consider a homology of C-Yoichi and the other type HA-33, the phylogenetic tree was 
made by UPGMA based on amino-acid sequence. 
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2.2 Comparison of the 3D structure of HA-33 
3D structure of HA-33 molecules were prepared and compared by using PyMOL 
(DeLano Scientiﬁc).  
 
2.3 Sugar recognition site prediction of C-Yoichi HA-33  
Prediction of sugar-recognition site of C-Yoichi HA-33 was performed with a 
eF-seek (http://ef-site.hgc.jp/eF-seek/top.do). 
 
3. Results and discussion 
At first the author attempted to classify the HA-33 based on the molecular 
evolution and to determine the motif in HA-33/C-Yoichi that is responsible for the 
sugar-recognition. Fig.1 shows a phylogenetic tree of HA-33 created by applying the 
amino acid sequence of HA-33 to an unweighted pair group method with arithmetic 
mean. HA-33 was divided into three groups: serotypes A and B (A/B), serotypes C and 
D (C/D), and serotype G. As mentioned in former chapters, serotypes A/B and serotypes 
C/D have been shown to recognize galactose and sialic acid, respectively. Thus it is 
considered that sugar-recognizing property of HA-33 molecule is associated with its 
evolution. On the other hand, HA-33/C-Yoichi was involved in not serotypes A/B group 
but serotypes C/D group in this classification although it recognizes galactose similarly 
to serotypes A/B. Thus HA-33/C-Yoichi recognizes galactose regardless of low 
homology to serotypes A/B, suggesting that the galactose-recognizing motif in 
HA-33/C-Yoichi is distinct from that in HA-33 of serotypes A/B.  
Fig. 2 shows schematic models for the three dimensional structure of HA-33/ 
serotype A strain 62A (A-62A) and C-St. It has been shown that HA-33/A-62A has a 
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sugar recognition motif, Site A, in its β-trefoil domain in which Asp263, Gly266, 
Gln276, Phe278, His281 and Asn285 contribute to interact with galactose. Although 
HA-33/C-Yoichi recognizes galactose similarly to HA-33/A-62A, it lacks the region 
corresponding to Site A, suggesting again that galactose-recognizing characteristics of 
HA-33/C-Yoichi is distinct from that of HA-33/A-62A. It has also been shown that 
HA-33/C-St has two motifs (Site Ic and IIc) for sugar recognition in its β-trefoil domain 
of C-terminal region. Site Ic involving Asn167, Leu168, Trp176, Phe179 and Arg183 
predominantly recognizes sialic acid, and W176 is responsible for the holding of an 
aromatic ring of sugar by stacking interaction. Site IIc involving Asp256D, Asn259, 
Asp271D, His274, Asn278 and Gln279 recognizes only sialic acid. In HA-33/C-Yoichi, 
the region corresponding to Site IIc is lacked but that to Site Ic existed; In the region 
corresponding to Site Ic, three amino acids were replaced but Trp176, that is 
prerequisite to hold aromatic ring in sugar, was preserved as Trp175. Thus the region 
corresponding to Site Ic might contribute to recognize galactose in HA-33/C-Yoichi 
(Fig.3). To obtain further insight, a sugar recognition site was predicted by eF-Seek, a 
database for ligand binding sites. When the sequence of amino acids of HA-33/C-Yoichi 
was applied to eF-Seek with a hemolysin of Vibrio vulnificus as a template motif, a 
galatose-recognition site was predicted to exist in β-trefoil domain of C-terminal region 
(Fig. 4). This region corresponded to Site Ic of HA-33/C-St, and eight amino acid 
residues (Asp164, Lys165, Asn166, Gln167, Trp175, Trp178 and Gln183) were 
predicted to contribute to bind galactose. As mentioned above, Trp175 is thought to hold 
aromatic ring in sugar. 
Collectively, it was presumed that galactose-recognizing mechanism of C-Yoichi 
HA-33 is different from that of HA-33/A and that a variation of amino acids in the 
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region corresponding to site Ic contributes to unique characteristics of sugar recognition 
in HA-33/C-Yoichi. 
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Fig. 1. Molecular dendrogram of C-Yoichi and the other type HA-33. To consider a homology of C-Yoichi and the other type HA-33, 
the phylogenetic tree was made by UPGMA based on amino-acid sequence.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Crystal structure of HA-33/A and C and close up views of the sugar-binding 
sites of HA-33.  Structure of HA-33/A-62A (upper panel) and C-St (lower panel) as 
represented by a ribbon diagram. Close up view of site Ic bound sialic acid. 
Sugar-binding residues is represented using a stick model. close up view of site IIc and 
Site A bound galctose. 
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Fig. 3. Superimposed illustrations of the area near the sugar binding sites of 
HA-33/ C-St and C-Yoichi. Close-up view of the β-trefoil domain for C-terminal 
of HA-33/C-St superimposed on the same region of HA-33/C-Yoichi with a Galctose 
molecule model. The putative sugar binding residues as observed in type C HA-33/C-St 
(green) and their counterparts in HA-33/C-Yoichi (blue). Residue labels are indicated 
for HA-33/C-Yoichi; those from HA-33/C-St structure are in parentheses.  
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Fig. 4. Superimposed illustrations of the area near the expected sugar binding sites 
of HA-33/C-Yoichi and Vibrio vulnificus Hemolysin/Cytolysi. Close-up view of theβ
-trefoil domain for C-terminal of HA-33/C-Yoichi superimposed on the same region 
of ibrio vulnificus Hemolysin/Cytolysin with a Galctose molecule model. The putative 
sugar binding residues as observed in HA-33/C-Yoichi (blue) and their counterparts in 
ibrio vulnificus Hemolysin/Cytolysin (purple). Residue labels are indicated for 
HA-33/C-Yoichi; those from theibrio vulnificus Hemolysin/Cytolysin structure are in 
parent. 
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Summary 
In this section the specific site responsible for the carbohydrate recognition of 
HA-33/C-Yoichi was determined based on the arrangement of amino acids in 3D 
structure. Comparison of 3D structure of HA-33/C-Yoichi, serotype A strain 62A 
(A-62A) and C-St demonstrated that HA-33/C-Yoichi lacks the region corresponding to 
Site A that recognizes galactose in HA-33/A-62A. In β-trefoil domain of C-terminal 
region, HA-33/C-Yoichi has a region corresponding to Site Ic that recognizes galactose 
in C-St; in the region corresponding to Site Ic, three amino acids were replaced but 
176W, that is prerequisite to hold aromatic ring in sugar, was preserved as W175. When 
the sequence of amino acids of HA-33/C-Yoichi was applied to eF-Seek, a database for 
ligand-binding site, a galatose-recognition site was predicted to exist in β-trefoil domain 
of C-terminal region corresponded to Site Ic of HA-33/C-St. These results suggest that 
galactose-recognizing mechanism of HA-33/C-Yoichi is different from that of HA-33/A 
and that a variation of amino acids in the region corresponding to site Ic contributes to 
unique characteristics of sugar recognition in HA-33/C-Yoichi.  
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ABSTRACT 
Clostridium botulinum produces a botulinum neurotoxin (BoNT) that is the 
causative agent of human and animal botulism. After the absorption from intestine, 
BoNT enters nerve cells and cleaves specific sites on target proteins. This results in the 
inhibition of acetylcholine release and flaccid muscle paralysis. BoNT is serologically 
classified into seven serotypes A through G. Serotype A, B, E and F are mainly 
responsible for human botulism, whereas serotypes C and D causes in animal and avian 
botulism. In culture supernatant and naturally contaminated foods, BoNT molecule is 
associated with auxiliary proteins including nontoxic nonhemagglutinin (NTNHA) and 
hemagglutinin (HA) subcomponents having molecular mass of 70, 33 and 17 kDa 
(HA-70, HA-33 and HA-17), yielding botulinum toxin complex (TC). Although the 3D 
structure of L-TC has long been obscure, a recent study by Hasegawa et al. clarified that 
L-TC has an ellipsoidal-shaped structure with three extended “arms” of the 
HA-33/HA-17 (2:1) trimer.  
HA-33/HA-17 trimer is thought to contribute to the effective transport of the toxin 
across the intestinal epithelia. It has been shown that HA-33 binds to intestinal cells via 
sugar chains on the cell surface, and that HA-33 of serotype A and B (HA-33/A and /B) 
predominantly recognizes galactose whereas HA-33 of serotype C and D (HA-33/C and 
/D) preferentially binds to sialic acid moiety but not galactose moiety on the cell 
surface.  
Sagane et al. (2001) demonstrated that HA-33 of serotype C strain Yoichi 
(C-Yoichi), showing poor hemagglutination activity, has a deletion of 31 amino acid 
residues from the C-terminus and that the HA-33/C-Yoichi showed only 46% amino 
acid identity in the C-terminal half region compared with a reference serotype C strain. 
72 
 
A recent study reported that L-TC/C-Yoichi showed full cell-binding activity when the 
cells were pretreated with neuraminidase, and the binding was completely inhibited in 
the presence of galactose or lactose (Matsuo et al., 2011). Thus HA-33/C-Yoichi shows 
unique sugar-recognizing property that binds to the galactose like HA-33/A and /B, 
whereas other serotype C and D HA-33 preferentially binds to sialic acid. 
Although it is likely that the unusual recognition of the galactose moiety of 
HA-33/C-Yoichi could be due to mutations and/or a truncation of the protein, the 
mechanism by which this protein recognizes galactose unlike other serotype C strains is 
still unknown. In this study, the author focused on the structure of HA-33/C-Yoichi and 
investigated its unique sugar recognition mechanism. In this thesis, the author compared 
the binding of HA-33/C-Yoichi and HA-33 from serotype C strain Stockholm (C-St) 
that recognizes sialic acid, to several types of epithelial cells to confirm the functional 
difference (Chapter I). Further, the author attempted crystallization of HA-33/C-Yoichi 
to perform X-ray analysis (Chapter II). Finally, the author determined the 
three-dimensional (3D) structures of HA-33/C-Yoichi and HA-33 from other C and D 
strains in a crystal and solution, and made prediction for the specific site responsible for 
the sugar recognition of HA-33/C-Yoichi based on 3D structure and in silico analysis 
(Chapter III). 
 
Chapter I. Host-cell and sugar-binding specificity of the HA-33 from Clostridium 
botulinum serotype C strain Yoichi  
In this chapter the author investigated the binding of HA-33/HA-17 trimer to 
epithelial cells to clarify the function of HA-33/C-Yoichi in intoxication, using rat 
intestinal cell line (IEC-6), bovine aortic endothelial cells (BAEC) and human colon 
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carcinoma (Caco-2). The binding of C-Yoichi HA-33/HA-17 trimer to cells was smaller 
or larger than that of C-St in IEC-6 or Caco-2, respectively. HA-33/HA-17 trimer of 
both strains bound to BAEC to the same extent, implying that HA-33 of two strains 
recognizes cells with different mechanisms. Pre-treatment of the cells by neuraminidase 
inhibited the binding of C-St trimer toward the cells, whereas dramatically increased 
cell binding of the C-Yoichi trimer. This finding suggests that the HA-33/C-Yoichi, 
similar to HA-33/A and /B, binds to the cells via sugar chain having galactose on its 
terminus, regardless of animal species and tissular origin of host-cell.  
 
Chapter II. Crystallization and preliminary X-ray analysis of a HA-33 from 
Clostridium botulinum serotype C strain Yoichi 
In this chapter the author performed crystallization and X-ray analysis of HA-33/ 
C-Yoichi that recognizes galactose unlike major serotype C strains. The C-Yoichi ha-33 
gene was amplified by PCR and was cloned into Escherichia coli TOP 10 to produce 
the recombinant HA-33 (rHA-33). Crystallization of rHA-33 was attempted under 286 
patterns of various conditions including temperature, protein concentration, 
precipitation drug and buffer in reservoir solution by the hanging drop method. When 
incubated under the condition of 5.0 mg/ml protein, 8% (w/v) polyethylene glycol 8000, 
0.1 M Tris buffer of pH 8.5 at 4˚C, crystals appeared within 3 d of incubation and grew 
to maximum dimensions of 0.01 × 0.01 × 0.2 mm. Thus the author succeeded in 
producing a crystal of C-Yoichi HA-33, which is available for X-ray analysis, for the 
first time. X-ray analysis of the crystal demonstrated that a resolution was 2.2 A ̊ and 
that the crystal belonged to space group R3 with Unit-cell parameters of a = b = 142.52 
Å and c = 126.79 Å. 
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Chapter III. Determination of 3D structure and prediction of the sugar-binding 
sites of HA-33 from Clostridium botulinum serotype C strain Yoichi 
In this chapter the author determined the 3D structures of HA-33/C-Yoichi in the 
crystal and solution and compared with those of other HA-33/C and D. Crystallographic 
analysis revealed that HA-33/C-Yoichi is a V-shaped dimer and that each HA-33 
molecule consists of N- and C-terminal β-trefoil domains that are connected by α-helix 
site. The angle made by upper C-terminal domains was slightly greater in 
HA-33/C-Yoichi than that in HA-33/C-St. The solution structures of HA-33/HA-17 
trimers of C-Yoichi and D-4947 were determined with small-angled X-ray scattering 
(SAXS). When the structures of D-4947 HA-33/HA-17 trimer in crystal and solution 
were superimposed, the structure in solution roughly corresponded to that in crystal. On 
the other hand, the solution structure of C-Yoichi trimer was largely different from 
crystal structure. Thus solution structure of C-Yoichi HA-33/HA-17 trimer was not 
symmetrical, and the angle made by two HA-33 molecules was larger than that in 
crystallographic structure. The results clearly demonstrated that 3D structure of 
C-Yoichi HA-33/HA-17 trimer was different from those from majority of the serotype C 
and D in solution. It is likely that the unique sugar recognition of HA-33/C-Yoichi can 
be attributed to its distinct 3D structure. 
Additionally, the specific site responsible for the sugar recognition of 
HA-33/C-Yoichi was predicted based on the 3D structure and in silico analysis. 
Considering the sugar-biding specificity, it was presumed that the sugar-binding site in 
the HA-33/C-Yoichi would be similar to that in the HA-33/A that recognizes galactose. 
In the HA-33/A, the galactose-binding site is located in the C-terminal region of the 
protein. Comparison of 3D structure of HA-33/C-Yoichi and /A demonstrated that 
75 
 
HA-33/C-Yoichi however lacks the region corresponding to the site that recognizes 
galactose in HA-33/A. Thus the galactose-recognizing characteristic of HA-33/C-Yoichi 
is distinct from that of HA-33/A. The HA-33/C protein that recognizes the sialic acid 
contains two sugar-binding sites Ic and IIc. On the other hand, in HA-33/C-Yoichi, the 
region corresponding to Site IIc is lacked but that to Site Ic existed. The Site Ic in the 
HA-33/C and /D that bind to the sialic acid is involved in the recognition of sialic-acid 
moiety. However, in the region corresponding to Site Ic of HA-33/C-Yoichi, even 
though the Trp176, that is prerequisite to hold aromatic ring in sugar, was preserved; 
three of five amino acid residues responsible for the sugar recognition were replaced. It 
was presumed that this mutation would bring the shift in sugar-recognition manner 
(sialic acid  galactose) to the HA-33 molecule. Sugar-binding site search using the 
ligand binding site database eF-seek indicated that a structure similar to 
galactose-recognition site in the Vibrio vulnificus hemolysin exists in the Site Ic region 
in the C-Yoichi HA-33. These results suggest that the galactose-recognizing manner of 
HA-33/C-Yoichi was evolved from sialic acid-recognizing HA-33 of the serotype C and 
D, not from galactose-recognizing HA-33 of the serotype A and B. 
 
In this thesis, the author demonstrated that the C-Yoichi HA-33 recognizes galactose 
regardless of cell types, dissimilar to majority of HA-33/C and /D. The author 
succeeded in crystallization and X-ray analysis of C-Yoichi HA-33 protein. Further the 
author demonstrated that 3D structure of C-Yoichi HA-33/HA-17 trimer was different 
from that of other serotype C and D strains in solution. Furthermore, a 
galactose-recognition site was predicted to exist in the HA-33/C-Yoichi protein. The 
results in this thesis would contribute a knowledge showing the protein evolution 
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occurring in the relationship between toxic protein and the host animal. The results of 
this study indicate new insights in the pathogenesis of botulism in humans and livestock. 
It is believed to contribute significantly to the establishment of prevention and treatment 
of botulism. 
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ABSTRACT (in Japanese) 
ボツリヌス菌（Clostridium botulinum）は、ヒトや動物のボツリヌス症の原因
となるボツリヌス神経毒素（botulinum neurotoxin; BoNT）を産生する。腸管から
吸収された BoNT は、神経細胞に侵入し、神経伝達物質の放出に関与するタン
パク質を特異的に切断することで神経伝達を阻害し、筋肉の麻痺を引き起こす。
BoNT は抗原性の違いにより A から G 型の 7 種に分類され、A、B、E および F
型は主にヒトの、CおよびD型はウシや家禽のボツリヌス症の原因となる。BoNT
は培養液や汚染食品中では単独で存在せず、非毒非血球凝集素（nontoxic 
nonhemagglutinin; NTNHA）や分子量 70、33 および 17 kDaの 3種の血球凝集素
（hemagglutinin; HA-70、HA-33 および HA-17）などの無毒タンパク質と会合し
た巨大な毒素複合体（large toxin complex; L-TC）を形成する。L-TC の詳細な構
造は長い間不明であったが、近年、Hasegawa ら（2007）によって、立体構造が
明らかにされ、L-TC が 1 分子の BoNT、1 分子の NTNHA、3 分子の HA-70、6
分子の HA-33 および 3 分子の HA-17 から構成される 14 量体であり、3 本の
HA-33/HA-17 （2:1）複合体が「腕」のように L-TC の表面に突き出しているこ
とが明らかにされた。 
HA-33/HA-17複合体は、L-TC の腸管上皮からの効率的な吸収に寄与していると
考えられている。すなわち、HA-33 が細胞表面の糖鎖を認識して小腸上皮細胞
と結合し、腸管から体内への侵入を促進する。しかし、認識する糖の特異性は
血清型によって異なり、Aおよび B型 HA-33 はガラクトースを認識するのに対
し、C および D型 HA-33はシアル酸を認識する。 
先に Sagane らは、C 型菌 Yoichi 株（C-Yoichi）の産生する HA-33 において、そ
の C 末端側 31アミノ酸残基が欠落していること、そしてその C 末端側 1/2 の領
域の相同性が他の C 型 HA-33 と比較し、46%と顕著に低いことを示した。さら
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に、Matsuo ら（2011）は、C-Yoichi L-TC が、ノイラミニターゼ処理した細胞に
のみ結合し、さらにその結合がガラクトースによって完全に阻害されることを
明らかにした。すなわち、他の C および D型 HA-33がシアル酸を認識するのに
対し、C-Yoichi HA-33 は、A および B 型のようにガラクトースを認識する特殊
な糖鎖認識特異性を持つことが示唆された。 
C-Yoichi HA-33 の C 末端側の変異および欠落が糖鎖の認識特異性に何らかの影
響を与えていることが推測される。しかし、C-Yoichi HA-33 が、なぜ他の C お
よび D型 HA-33と異なる糖鎖認識機構を示すのかについては、不明のままであ
った。本論文では C-Yoichi HA-33 の特異な糖認識機構を明らかにするため、ガ
ラクトース認識型である C-Yoichi HA-33 とシアル酸認識型である C 型菌
Stockholm 株（C-St）由来 HA-33の各種細胞への結合活性を比較し、それぞれの
機能の差異を明らかにした（第 1章）。次に、C-Yoichi HA-33の立体構造の特異
性を明らかにするため、C-Yoichi HA-33の結晶化および X線回折を分析し（第 2
章）、さらに他の C および D 型由来のシアル酸認識型 HA-33 の立体構造との比
較を行った。また、立体構造およびコンピュータ解析をもとに C-Yoichi HA-33
分子内の糖認識部位を予測し、糖鎖への結合メカニズムを推測した（第 3 章）。 
 
第 1章 ボツリヌスC型菌Yoichi株由来HA-33が結合する細胞種および糖鎖の
特異性 
本章では、細胞結合における C-Yoichi HA-33 の機能を明らかにするため、
HA-33/HA-17複合体の各種細胞（ラット小腸上皮細胞 IEC-6、ウシ大動脈内皮細
胞 BAEC およびヒト大腸癌由来細胞 Caco-2）への結合活性を比較した。その結
果、IEC-6では C-Yoichi HA-33の方が、Caco-2では C-St HA-33の方が、より高
い結合活性を示した。また、BAEC では、結合量はいずれも同程度であった。こ
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のことから、C-Yoichi および C-St 由来 HA-33 は、それぞれ異なる機構によって
細胞に結合していることが示唆された。一方、ノイラミニターゼにより細胞表
面のシアル酸を除去すると、細胞種に関係なく C-St HA-33の結合量は減少し、
C-Yoichi HA-33の結合量は上昇した。以上の結果から、C-Yoichi HA-33 は、Aお
よび B型 HA-33と同様に、細胞の動物種あるいは組織種の違いにかかわらずガ
ラクトースを認識していることが示唆された。 
 
第 2章 ボツリヌス C型菌 Yoichi株由来 HA-33の結晶化および X線分析 
C-Yoichi HA-33の糖鎖認識特性は、その構造に起因するものと推測される。し
たがって、本章では、HA-33の立体構造解明するため、C-Yoichi HA-33 の結晶化
および X 線回折分析を行った。C-Yoichi 株 ha-33 遺伝子を PCR 法によって増幅
し、大腸菌 TOP10 株に導入し、組換え HA-33 （rHA-33）を得た。結晶化に適
した条件を明らかにするため、温度、タンパク質濃度、沈殿剤および緩衝液の
組み合わせをもとに 286 種類の条件で結晶化を試みた。その結果、ハンギング
ドロップ蒸気拡散法で、タンパク質濃度 5 mg/ml、温度 4℃、リザーバー溶液の
組成が 8% (w/v) PEG 8,000、0.1 M Tris hydrochloride、pH 8.5の条件で 0.01 × 0.01 
× 0.2 mm の大きさの柱状結晶を得ることができた。これにより、著者は X線解
析に供することのできる C-Yoichi HA-33 の結晶を作成することに世界で始めて
成功した。この結晶を、X線回折実験に供したところ、2.2Åの分解能が得られ、
C-Yoichi rHA-33の結晶は、空間群 R3に属し、格子定数は a = b = 142.52 Å、c = 
126.79 Åであることを明らかにした。 
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第 3章 ボツリヌス C型菌 Yoichi株由来 HA-33の立体構造および糖認識部位 
予測 
本章では、C-Yoichi HA-33の結晶構造および溶液構造を解析し、他の C および D
型 HA-33の構造と比較した。結晶構造解析の結果から、C-Yoichi HA-33は V字
型の 2量体として存在しており、それぞれの HA-33分子は N末端側と C 末端側
の 2 つの β-trefoil ドメインから構成されていた。2 量体の HA-33 分子の C 末端
側領域が形成する角度は、C-Yoichi HA-33のほうが C-St HA-33より若干外側に
広がっていたが、顕著な違いは認められなかった。さらに溶液中の HA-33/HA-17
複合体の立体構造を比較するため、C-Yoichi および D-4947 HA-33/HA-17複合体
を小角 X 線散乱法（SAXS）により解析した。その結果、D-4947 HA-33/HA-17
複合体（シアル酸結合型）の溶液構造は、結晶構造とその形状はほぼ一致して
いた。しかし、C-Yoichi HA-33/HA-17 の溶液中の構造は結晶構造とは大きく異
なっており、溶液中では、HA-17 を中心として 2 分子の HA-33 が左右に大きく
開いることが示唆された。以上の結果から、C-Yoichi HA-33/HA-17 複合体の溶
液中での立体構造は、他の C および D型 HA-33/HA-17複合体とは大きく異なっ
ていることが示された。 
さらに、立体構造の比較およびコンピュータ解析から C-Yoichi HA-33 の糖認識
部位を予測した。糖鎖への結合特異性から、C-Yoichi HA-33の糖鎖認識部位は、
ガラクトースを認識するA型HA-33と類似しているものと予測した。A型HA-33
は、その分子内の C 末端領域にガラクトース結合部位をもつ。しかし、C-Yoichi
および A型 HA-33の立体構造を比較したところ、A型のガラクトース結合部位
に相当する領域は、C-Yoichi HA-33 タンパク質から欠落した領域に存在していた。
したがって、予想とは異なり、C-Yoichi HA-33 のガラクトース結合部位は A 型
HA-33 のそれとは関連性が低いことが示された。一方、シアル酸を認識する C
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型 HA-33タンパク質には、2つの糖鎖認識部位（Site Icおよび IIc）が存在する。
C-Yoichi HA-33タンパク質では、Site IIcに相当する領域が欠落していたが、Site 
Ic に相当する部位は存在していた。シアル酸認識型の C および D型 HA-33分子
内において Site Icはシアル酸の認識に関与する。一方、C-Yoichi HA-33分子中
の Site Ic に相当する領域は、糖認識に関与すると予測される 5 アミノ酸残基の
うち、糖の芳香環との相互作用に関与すると考えられる Trp173 は保存されてい
たものの、3残基が変異していた。この変異が、C-Yoichi HA-33に糖認識機構の
変化（シアル酸→ガラクトース）をもたらしたものと推測された。さらに、リ
ガンド結合部位データベース検索 eF-seek により糖認識部位を予測したところ、
Vibrio vulnificus由来 hemolysin分子内のガラクトース結合部位に類似した構造が、
C-Yoichi HA-33分子内の Site Icに存在することが示された。以上の結果から、
C-Yoichi HA-33 のガラクトース認識部位は、ガラクトース認識型の A および B
型 HA-33 分子からではなく、シアル酸認識型の C および D 型 HA-33 から進化
して形成されたものであることが示唆された。 
 
本論文において、著者は、他の C および D型 HA-33とは異なり、C-Yoichi HA-33
が細胞の違いにかかわらず、シアル酸ではなく、ガラクトースを認識すること
を示した。また、C-Yoichi HA-33タンパク質の結晶化に初めて成功した。さらに、
C-Yoichi HA-33/HA-17 複合体の溶液構造が、他の C および D型由来の複合体と
は大きく異なっていることを明らかにし、他の型の HA-33 分子や糖鎖結合タン
パク質の立体構造との比較から、C-Yoichi HA-33分子内のガラクトース認識部位
を予測することに成功した。本研究の成果は、毒素タンパク質と宿主生物の間
の相互作用によって進行するタンパク質の分子進化に関わる重要な知見である。
また、ヒトや家畜のボツリヌス中毒の発症機序に新たな知見を加えるものであ
82 
 
る。現在でも家畜に対するボツリヌス中毒の発生は、世界中に散見されており、
本研究の成果は、その予防法や治療法の確立に大きく貢献するものと考えられ
る。 
 
 
